Product image of Lasca (Ethinylestradiol, Levonorgestrel | Lactose) supplied by GNH India

Lasca

Active Ingredient:
Ethinylestradiol, Levonorgestrel | Lactose
Origin:
EU

Lasca (Ethinylestradiol, Levonorgestrel | Lactose)

Ethinylestradiol and Levonorgestrel, the active ingredient in Lasca, is a combined estrogen‑progestogen oral contraceptive presented as a tablet for oral use. It works to prevent pregnancy in women of reproductive age by inhibiting ovulation and creating cervical mucus changes that reduce sperm penetration.

GNH India supplies Lasca as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory standards and is manufactured under GMP conditions.

Manufacturer / TM Owner

Exeltis Italia Srl

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lasca, a combined estrogen‑progestogen oral contraceptive, is used in hormonal contraception and related menstrual disorders.

  • Contraception (prevention of pregnancy): provides reliable hormonal birth control for women of childbearing age.
  • Menstrual cycle regulation: helps achieve more predictable bleeding patterns and reduces menstrual discomfort.
  • Acne improvement: decreases androgen‑driven skin lesions, leading to clearer complexion in some users.

How It Works

  • Ethinylestradiol binds to estrogen receptors while levonorgestrel binds to progesterone receptors, together suppressing the hypothalamic‑pituitary‑gonadal axis. This inhibition prevents the mid‑cycle surge of luteinizing hormone and follicle‑stimulating hormone, blocking ovulation. The progestogenic component also thickens cervical mucus and induces endometrial changes that diminish the chance of implantation.

Side Effects

Like all hormonal contraceptives, Lasca may cause a range of adverse reactions.

Common Side Effects

  • Nausea: mild stomach upset, often transient.
  • Breast tenderness: swelling or discomfort in the breasts.
  • Headache: mild to moderate intensity.
  • Spotting or breakthrough bleeding: irregular light bleeding between periods.

Serious or Rare Side Effects

  • Deep vein thrombosis: blood clot formation in veins, requiring immediate medical attention.
  • Pulmonary embolism: clot migration to lungs, a life‑threatening emergency.
  • Stroke: rare cerebrovascular event associated with hormonal therapy.
  • Severe allergic reaction: rash, swelling, or difficulty breathing.

Precautions & Warnings

Before prescribing Lasca, clinicians should consider several precautionary measures to ensure safe use.

  • Assess cardiovascular risk: avoid in women with history of thromboembolic disorders or uncontrolled hypertension.
  • Evaluate liver function: contraindicated in severe hepatic impairment.
  • Review smoking status: do not use in smokers over 35 years of age.
  • Counsel on medication adherence: missing tablets can reduce effectiveness.
  • Discuss potential drug interactions: inform about concomitant use of enzyme‑inducing agents.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and light.

Avoid Interactions

Lasca can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine): may markedly reduce contraceptive effectiveness.
  • Antifungal azoles (e.g., ketoconazole): can increase hormone levels, raising risk of side effects.
  • Certain antiretrovirals (e.g., efavirenz): may lower plasma concentrations, compromising contraception.

Moderate Interactions (Monitor Closely)

  • Antidepressants (e.g., sertraline): may slightly increase bleeding tendency.
  • Anticonvulsants with moderate enzyme induction (e.g., phenytoin): require monitoring of cycle control.
  • Herbal supplements (e.g., St. John’s wort): may modestly decrease hormonal levels.

Frequently Asked Questions

Lasca is a combined estrogen‑progestogen oral contraceptive indicated for the prevention of pregnancy in women of reproductive age. It may also be prescribed to help regulate menstrual cycles and to improve acne associated with hormonal fluctuations.

Ethinylestradiol activates estrogen receptors while levonorgestrel activates progesterone receptors. Together they suppress the hypothalamic‑pituitary‑gonadal axis, preventing the LH and FSH surge that triggers ovulation, and they thicken cervical mucus and alter the endometrium to reduce the chance of implantation.

The specific dosing regimen for Lasca is determined by the prescribing healthcare professional. Typically, the medication is taken once daily at the same time each day, but the exact number of tablets and duration of use are individualized based on clinical judgment.

Lasca is contraindicated during pregnancy because it is intended to prevent conception. Women who become pregnant should discontinue use immediately. While limited data exist for breastfeeding, the progestogen component may affect milk production, so clinicians usually advise caution and assess risks versus benefits.

To order Lasca, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any required import documentation.

Lasca contains the widely used dose combination of ethinylestradiol and levonorgestrel, offering a balance of efficacy and tolerability comparable to other second‑generation combined oral contraceptives. Its safety profile, side‑effect spectrum and drug‑interaction potential are similar to alternative products containing the same active ingredients.

Lasca tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original blister pack to protect from moisture and light. Do not store in bathrooms or near heat sources, and keep out of reach of children.

Lasca is taken orally, usually as one tablet each day at the same time. The tablet should be swallowed whole with water and can be taken with or without food. Consistent daily intake is essential for maintaining contraceptive effectiveness.

Serious risks, though rare, include thromboembolic events such as deep‑vein thrombosis, pulmonary embolism, and stroke. These events are more likely in women with pre‑existing cardiovascular risk factors, smoking history, or certain genetic predispositions. Prompt medical attention is required if symptoms of clotting occur.

Lasca is contraindicated in women with a history of thromboembolic disorders, uncontrolled hypertension, severe liver disease, known or suspected breast cancer, or those who are pregnant. It should also be avoided by smokers over 35 years of age and by individuals taking strong enzyme‑inducing medications that reduce contraceptive efficacy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ethinylestradiol, Levonorgestrel | Lactose

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT